Business Wire

1204 Articles

Grasshopper Dispensary – Holiday Toy Drive in Chula Vista – “Hop on in with a Toy Drive”

CHULA VISTA, Calif.--(BUSINESS WIRE)--#Cannabis--Grasshopper Dispensary invites you to “Hop on in with

Business Wire Business Wire

Coda Signature Announces New Board Member

Teddy C. Scott Brings Extensive Industry Experience, Strategic Growth Acumen DENVER--(BUSINESS WIRE)--Coda

Business Wire Business Wire

Coda Signature Announces New Board Member

Teddy C. Scott Brings Extensive Industry Experience, Strategic Growth Acumen DENVER--(BUSINESS WIRE)--Coda

Business Wire Business Wire

Northern Redwood Federal Credit Union Shifts Compliance & Risk Management Capabilities to NatureTrak

SACRAMENTO, Calif.--(BUSINESS WIRE)--#cannabisbanking--NatureTrak, the leading compliance and risk management solution for financial

Business Wire Business Wire

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

POTOMAC, Md.--(BUSINESS WIRE)--#Alzheimers--(NYSE American: IGC), India Globalization Capital, Inc. (IGC) is excited

Business Wire Business Wire

International Cannabis Brand Cookies and InterCure Announce European Expansion

Cookies Partners With Leading Global Cannabis Company InterCure to Open Retail Locations

Business Wire Business Wire

National Geographic Releases Second Season of Companion Podcast to Investigative Series TRAFFICKED WITH MARIANA VAN ZELLER

New Episodes of The Trafficked Podcast with Mariana van Zeller Available Weekly

Business Wire Business Wire

The Worldwide Denim Jeans Industry is Expected to Reach $87.4 Billion by 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Denim Jeans - Global Market Trajectory & Analytics" report has

Business Wire Business Wire

MyMD Pharmaceuticals to Participate in Two Investor Conferences During December 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator

Business Wire Business Wire

MyMD Pharmaceuticals to Participate in Two Investor Conferences During December 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator

Business Wire Business Wire